{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:14:06Z","timestamp":1793312046268,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T00:00:00Z","timestamp":1569196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T00:00:00Z","timestamp":1569196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo&#x0161;kog Razvoja","doi-asserted-by":"publisher","award":["ON175023"],"award-info":[{"award-number":["ON175023"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo&#x0161;kog Razvoja","doi-asserted-by":"publisher","award":["ON175023"],"award-info":[{"award-number":["ON175023"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Gentamicin, belonging to the aminoglycosides, possesses the greatest nephrotoxic effect of all other antibiotics from this group. On the other hand, pioglitazone, which represents peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) agonist recently showed antiinflamatory, antioxidative effects, amelioration of endothelial dysfunction etc. Therefore, the goal of our study was to investigate the effects of pioglitazone on kidney injury in an experimental model of gentamicin-induced nephrotoxicity in rats. These effects were observed by following values of biochemical (serum urea and creatinine) parametars, total histological kidney score, urine level of kidney injury molecule-1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) as well as parametars of oxidative stress (malondialdehyde, superoxide dismutase, catalase, total oxidant status, total antioxidant status, oxidative stress index and advanced oxidation protein products). It seems that pioglitazone protects the injured rat kidney in a U-shaped manner. Medium dose of pioglitazone (1\u2009mg\/kg, i.p.) was protective regarding biochemical (serum urea and creatinine), total histological score and the values of kidney injury molecule-1 (KIM-1) (P\u2009&lt;\u20090.05 vs. control group, i.e. rats injected with gentamicin only). This finding could be of great importance for the wider use of aminoglycosides, with therapy that would reduce the occurrence of serious adverse effects, such as nephrotoxicity and acute renal failure.<\/jats:p>","DOI":"10.1038\/s41598-019-49835-1","type":"journal-article","created":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T06:02:55Z","timestamp":1569218575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Pioglitazone attenuates kidney injury in an experimental model of gentamicin-induced nephrotoxicity in rats"],"prefix":"10.1038","volume":"9","author":[{"given":"Branislava","family":"Medi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marko","family":"Stojanovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branislav","family":"Rov\u010danin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Du\u0161an","family":"Keki\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanja Radojevi\u0107","family":"\u0160kodri\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordana Basta","family":"Jovanovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina Savi\u0107","family":"Vujovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevena","family":"Divac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radan","family":"Stojanovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"Radenkovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica","family":"Prostran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,9,23]]},"reference":[{"key":"49835_CR1","unstructured":"Trevor, A., Katzung, B. & Kruidering-Hall, M. Toxicity. In: Weitz, M & Lebowitz, H. editors. Pharmacology examination & board review. 11th edition. New York: McGraw-Hill; p. 378\u2013379 (2015)."},{"issue":"2","key":"49835_CR2","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1179\/joc.2010.22.2.88","volume":"22","author":"SI Al-Azzam","year":"2010","unstructured":"Al-Azzam, S. I., Abdul-Razzak, K. K. & Jarada, M. W. The nephroprotective effects of pioglitazone and glibenclamide against gentamicin-induced nephrotoxicity in rats: a comparative study. J. Chemother. 22(2), 88\u201391, https:\/\/doi.org\/10.1179\/joc.2010.22.2.88 (2010).","journal-title":"J. Chemother."},{"issue":"5","key":"49835_CR3","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.acthis.2006.06.005","volume":"108","author":"A Polat","year":"2006","unstructured":"Polat, A. et al. Protective role of aminoguanidine on gentamicin-induced acute renal failure in rats. Acta. Histochem. 108(5), 365\u201371, https:\/\/doi.org\/10.1016\/j.acthis.2006.06.005 (2006).","journal-title":"Acta. Histochem."},{"issue":"1","key":"49835_CR4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1046\/j.0767-3981.2003.00211.x","volume":"18","author":"Y Karatas","year":"2004","unstructured":"Karatas, Y. et al. Effect of tempol (4-hydroxy tempo) on gentamicin-induced nephrotoxicity in rats. Fundam. Clin. Pharmacol. 18(1), 79\u201383 (2004).","journal-title":"Fundam. Clin. Pharmacol."},{"issue":"5","key":"49835_CR5","first-page":"548","volume":"18","author":"R Ghaznavi","year":"2005","unstructured":"Ghaznavi, R., Faghihi, M., Kadkhodaee, M., Shams, S. & Khastar, H. Effects of nitric oxide on gentamicin toxicity in isolated perfused rat kidneys. J. Nephrol. 18(5), 548\u201352 (2005).","journal-title":"J. Nephrol."},{"key":"49835_CR6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1530\/eje.1.02134","volume":"154","author":"P Iglesias","year":"2006","unstructured":"Iglesias, P. & D\u0131\u00b4ez, J. Peroxisome proliferator-activated receptor gamma agonists inrenal disease. Eur. J. Endocrinol. 154, 613\u2013621 (2006).","journal-title":"Eur. J. Endocrinol."},{"key":"49835_CR7","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/sj.ki.5001620","volume":"70","author":"PA Sarafidis","year":"2006","unstructured":"Sarafidis, P. A. & Bakris, G. L. Protection of the kidney by thiazolidinediones: An assessment from bench to bedside. Kidney. Int. 70, 1223\u20131233, https:\/\/doi.org\/10.1038\/sj.ki.5001620 (2006).","journal-title":"Kidney. Int."},{"issue":"4","key":"49835_CR8","doi-asserted-by":"publisher","first-page":"F1141","DOI":"10.1152\/ajprenal.00288.2005","volume":"292","author":"S Ohga","year":"2007","unstructured":"Ohga, S. et al. Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of nF-kB activation. Am. J. Physiol. Renal. Physiol. 292(4), F1141\u201350, https:\/\/doi.org\/10.1152\/ajprenal.00288.2005 (2007).","journal-title":"Am. J. Physiol. Renal. Physiol."},{"issue":"5","key":"49835_CR9","doi-asserted-by":"publisher","first-page":"e95313","DOI":"10.1371\/journal.pone.0095313","volume":"9","author":"D Ragab","year":"2014","unstructured":"Ragab, D., Abdallah, D. M. & El-Abhar, H. S. Cilostazol renoprotective effect: modulation of PPAR-\u03b3, NGAL, KIM-1 and IL-18 underlies its novel effect in a model of ischemia-reperfusion. PLoS One 9(5), e95313, https:\/\/doi.org\/10.1371\/journal.pone.0095313 (2014).","journal-title":"PLoS One"},{"issue":"8","key":"49835_CR10","first-page":"1175","volume":"15","author":"A Erdem","year":"2000","unstructured":"Erdem, A. et al. The protective effect of taurine against gentamicin-induced acute tubular necrosis in rats. nephrol Dial. Transplant. 15(8), 1175\u201382 (2000).","journal-title":"Transplant."},{"key":"49835_CR11","unstructured":"Wiland, P. & Szechcinski, J. Proximal tubule damage in patients treated with gentamicin or amikacin. Pol. J. Pharmacol. 55\n                           (\n                           4\n                           ), 631\u20137 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/14581723 (2003)."},{"issue":"3","key":"49835_CR12","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.tox.2005.07.007","volume":"215","author":"I Karahan","year":"2005","unstructured":"Karahan, I., Atessahin, A., Yilmaz, S., Ceribasi, A. O. & Sakin, F. Protective effect of lycopene on gentamicin-induced oxidative stress and nephrotoxicity in rats. Toxicology 215(3), 198\u2013204, https:\/\/doi.org\/10.1016\/j.tox.2005.07.007 (2005).","journal-title":"Toxicology"},{"issue":"6","key":"49835_CR13","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1159\/000452592","volume":"41","author":"QH Luo","year":"2016","unstructured":"Luo, Q. H. et al. Evaluation of KIM-1 and NGAL as Early Indicators for Assessment of Gentamycin-Induced Nephrotoxicity In Vivo and In Vitro. Kidney Blood Press Res. 41(6), 911\u2013918, https:\/\/doi.org\/10.1159\/000452592 (2016).","journal-title":"Kidney Blood Press Res."},{"issue":"1\u20132","key":"49835_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11010-014-2171-7","volume":"397","author":"QH Luo","year":"2014","unstructured":"Luo, Q. H. et al. KIM-1 and NGAL as biomarkers of nephrotoxicity induced by gentamicin in rats. Mol. Cell. Biochem. 397(1\u20132), 53\u201360 (2014).","journal-title":"Mol. Cell. Biochem."},{"key":"49835_CR15","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1248\/bpb.34.693","volume":"34","author":"X Kong","year":"2011","unstructured":"Kong, X., Zhang, D. Y., Wu, H. B. & Li, F. X. Losartan and pioglitazone ameliorate nephropathy in experimental metabolic syndrome rats. Biol. Pharm. Bull. 34, 693\u20139 (2011).","journal-title":"Biol. Pharm. Bull."},{"key":"49835_CR16","doi-asserted-by":"publisher","first-page":"858690","DOI":"10.1155\/2013\/858690","volume":"2013","author":"M Kuru Karabas","year":"2013","unstructured":"Kuru Karabas, M., Ayhan, M., Guney, E., Serter, M. & Meteoglu, I. The effect of pioglitazone on antioxidant levels and renal histopathology in streptozotocin-induced diabetic rats. ISRN Endocrinol. 2013, 858690, https:\/\/doi.org\/10.1155\/2013\/858690 (2013).","journal-title":"ISRN Endocrinol."},{"key":"49835_CR17","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.jss.2012.08.020","volume":"182","author":"B Reel","year":"2013","unstructured":"Reel, B. et al. The effects of PPAR-gamma agonist pioglitazone on renal ischemia\/reperfusion injury in rats. J. Surg. Res. 182, 176\u201384, https:\/\/doi.org\/10.1016\/j.jss.2012.08.020 (2013).","journal-title":"J. Surg. Res."},{"key":"49835_CR18","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.lfs.2006.12.004","volume":"80","author":"J Chaudhry","year":"2007","unstructured":"Chaudhry, J., Ghosh, N. N., Roy, K. & Chandra, R. Antihyperglycemic effect of a new thiazolidinedione analogue and its role in ameliorating oxidative stress in alloxan-induced diabetic rats. Life. Sci. 80, 1135\u201342, https:\/\/doi.org\/10.1016\/j.lfs.2006.12.004 (2007).","journal-title":"Life. Sci."},{"key":"49835_CR19","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1016\/j.jss.2013.03.027","volume":"184","author":"C Zou","year":"2013","unstructured":"Zou, C., Hu, H., Xi, X., Shi, Z. & Huang, X. Pioglitazone protects against renal ischemia-reperfusion injury by enhancing antioxidant capacity. J. Surg. Res. 184, 1092\u20131095, https:\/\/doi.org\/10.1016\/j.jss.2013.03.027 (2013).","journal-title":"J. Surg. Res."},{"issue":"5","key":"49835_CR20","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1159\/000443121","volume":"38","author":"L Sun","year":"2016","unstructured":"Sun, L. et al. Pioglitazone, a Peroxisome Proliferator-Activated Receptor x03B3; Agonist, Ameliorates Chronic Kidney Disease by Enhancing Antioxidative Capacity and Attenuating Angiogenesis in the Kidney of a 5\/6 Nephrectomized Rat Model. Cell. Physiol. Biochem. 38(5), 1831\u201340, https:\/\/doi.org\/10.1159\/000443121 (2016).","journal-title":"Cell. Physiol. Biochem."},{"issue":"12","key":"49835_CR21","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/sj.ki.5002248","volume":"71","author":"T Kanjanabuch","year":"2007","unstructured":"Kanjanabuch, T. et al. PPAR-gamma agonist protects podocytes from injury. Kidney Int. 71(12), 1232\u20139, https:\/\/doi.org\/10.1038\/sj.ki.5002248 (2007).","journal-title":"Kidney Int."},{"issue":"1","key":"49835_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/labinvest.2008.104","volume":"89","author":"T Kawai","year":"2009","unstructured":"Kawai, T. et al. PPAR-gamma agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-beta. Lab. Invest. 89(1), 47\u201358, https:\/\/doi.org\/10.1038\/labinvest.2008.104 (2009).","journal-title":"Lab. Invest."},{"key":"49835_CR23","doi-asserted-by":"publisher","first-page":"c230","DOI":"10.1159\/000224789","volume":"112","author":"Z Mao","year":"2009","unstructured":"Mao, Z. & Ong, A. C. PPAR-gamma agonists in kidney disease - future promise, present fears. Nephron. Clin. Pract. 112, c230\u2013c241, https:\/\/doi.org\/10.1159\/000224789 (2009).","journal-title":"Nephron. Clin. Pract."},{"key":"49835_CR24","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1681\/ASN.2008111138","volume":"20","author":"HC Yang","year":"2009","unstructured":"Yang, H. C. et al. The PPARgamma agonist pioglitazone ameliorates aging-related progressive renal injury. J. Am. Soc. Nephrol. 20, 2380\u20132388, https:\/\/doi.org\/10.1681\/ASN.2008111138 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"49835_CR25","first-page":"184","volume":"43","author":"R Mousleh","year":"2018","unstructured":"Mousleh, R., Al Laham, S. & Al-Manadili, A. The Preventive Role of Pioglitazone in Glycerol-Induced Acute Kidney Injury in Rats during Two Different Treatment Periods. Iran. J. Med. Sci. 43(2), 184\u2013194 (2018).","journal-title":"Iran. J. Med. Sci."},{"key":"49835_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/srep24392","volume":"6","author":"S Agrawal","year":"2016","unstructured":"Agrawal, S. et al. Pioglitazone Enhances the Beneficial Effects of Glucocorticoids in Experimental Nephrotic Syndrome. Sci Rep. 6, 24392, https:\/\/doi.org\/10.1038\/srep24392 (2016).","journal-title":"Sci Rep."},{"issue":"2","key":"49835_CR27","doi-asserted-by":"publisher","first-page":"e6812","DOI":"10.1590\/1414-431X20176812","volume":"51","author":"W Hai","year":"2017","unstructured":"Hai, W., Ping, X., Zhi-Wen, Y. & Chun, Z. Therapeutic effect and potential mechanism of pioglitazone in rats with severe acute pancreatitis. Braz. J. Med. Biol. Res. 51(2), e6812, https:\/\/doi.org\/10.1590\/1414-431X20176812 (2017).","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"11","key":"49835_CR28","doi-asserted-by":"publisher","first-page":"e0142303","DOI":"10.1371\/journal.pone.0142303","volume":"10","author":"MM Helmy","year":"2015","unstructured":"Helmy, M. M., Helmy, M. W. & El-Mas, M. M. Additive Renoprotection by Pioglitazone and Fenofibrate against Inflammatory, Oxidative and Apoptotic Manifestations of Cisplatin Nephrotoxicity: Modulation by PPARs. PLoS One 10(11), e0142303, https:\/\/doi.org\/10.1371\/journal.pone.0142303 (2015).","journal-title":"PLoS One"},{"key":"49835_CR29","doi-asserted-by":"publisher","unstructured":"Kvandova, M. et al. The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves nitric oxide availability, renin-angiotensin system and aberrant redox regulation in the kidney of pre-hypertensive rats. J Physiol Pharmacol. 69\n                           (\n                           2\n                           ), https:\/\/doi.org\/10.26402\/jpp.2018.2.09 (2018).","DOI":"10.26402\/jpp.2018.2.09"},{"issue":"4","key":"49835_CR30","doi-asserted-by":"publisher","first-page":"709","DOI":"10.3797\/scipharm.1407-16","volume":"82","author":"M Radenkovi\u0107","year":"2014","unstructured":"Radenkovi\u0107, M. Pioglitazone and Endothelial Dysfunction: Pleiotropic Effects and Possible Therapeutic Implications. Sci. Pharm. 82(4), 709\u201321, https:\/\/doi.org\/10.3797\/scipharm.1407-16 (2014).","journal-title":"Sci. Pharm."},{"issue":"1-2","key":"49835_CR31","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11010-016-2718-x","volume":"417","author":"AP Singh","year":"2016","unstructured":"Singh, A. P., Singh, N. & Bedi, P. M. Pioglitazone ameliorates renal ischemia reperfusion injury through NMDA receptor antagonism in rats. Mol. Cell. Biochem. 417(1-2), 111\u20138, https:\/\/doi.org\/10.1007\/s11010-016-2718-x (2016).","journal-title":"Mol. Cell. Biochem."},{"issue":"1-2","key":"49835_CR32","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"M Bradford","year":"1976","unstructured":"Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248\u201354, https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/942051 (1976).","journal-title":"Analytical Biochemistry"},{"key":"49835_CR33","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/00005792-197909000-00003","volume":"58","author":"K Solez","year":"1979","unstructured":"Solez, K., Morel-Maroger, L. & Sraer, J. D. The morphology of acute tubular necrosis in man: analysis of 57 renal biopsies and a comparasion with the glycerol model. Medicine 58, 362\u2013366 (1979).","journal-title":"Medicine"},{"issue":"5","key":"49835_CR34","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1080\/09553009014552121","volume":"58","author":"R Varshney","year":"1990","unstructured":"Varshney, R. & Kale, R. K. Effects of calmodulin antagonists on radiation-induced lipid peroxidation in microsomes. Int. J. Radiat. Biol. 58(5), 733\u201343 (1990).","journal-title":"Int. J. Radiat. Biol."},{"issue":"1","key":"49835_CR35","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0003-2697(78)90010-6","volume":"90","author":"M Sun","year":"1978","unstructured":"Sun, M. & Zigman, S. An improved spectrophotometric assay for superoxide dismutase based on epinephrine autoxidation. Anal. Biochem. 90(1), 81\u20139 (1978).","journal-title":"Anal. Biochem."},{"issue":"1","key":"49835_CR36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0021-9258(19)50881-X","volume":"195","author":"RF Beers","year":"1952","unstructured":"Beers, R. F. & Sizer, I. W. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J. Biol. Chem. 195(1), 133\u201340 (1952).","journal-title":"J. Biol. Chem."},{"issue":"12","key":"49835_CR37","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.clinbiochem.2005.08.008","volume":"38","author":"O Erel","year":"2005","unstructured":"Erel, O. A new automated colorimetric method for measuring total oxidant status. Clin. Biochem. 38(12), 1103\u201311, https:\/\/doi.org\/10.1016\/j.clinbiochem.2005.08.008 (2005).","journal-title":"Clin. Biochem."},{"issue":"4","key":"49835_CR38","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.clinbiochem.2003.11.015","volume":"37","author":"O Erel","year":"2004","unstructured":"Erel, O. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin. Biochem. 37(4), 277\u201385, https:\/\/doi.org\/10.1016\/j.clinbiochem.2003.11.015 (2004).","journal-title":"Clin. Biochem."},{"issue":"5","key":"49835_CR39","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/ki.1996.186","volume":"49","author":"V\u00e9ronique Witko-Sarsat","year":"1996","unstructured":"Witko-Sarsat, V. et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney. Int. 49\n                           (\n                           5\n                           ), 1304\u201313, https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8731095 (1996).","journal-title":"Kidney International"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49835-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49835-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49835-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T08:54:12Z","timestamp":1671267252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-49835-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,23]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["49835"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-49835-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736661522.793568034","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,23]]},"assertion":[{"value":"14 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"13689"}}